The comparison of the clinical utility between two kinds of bowel preparations (NaP Tablets and PEG salt solution) - The comparison of the clinical utility between two kinds of bowel preparations (NaP Tablets and PEG salt solution)

TT Medical Center Tokyo, Gastroenterology Division0 个研究点目标入组 500 人开始时间: 2011年5月11日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•A. Those who are true of contraindication to NaP or PEG solution: 1. patients with congestive heart failure or unstable angina, 2. patients with long QT syndrome or critical ventricular arrhythmia, 3. patients with ascites, 4. patients with or suspected of ileus, 5. patients with or suspected of bowel perforation, 6. patients with toxic megacolon, 7. patients with critical renal failure including hemodialysis patients and patients with acute phosphate nephropathy and 8. patients with a history of hypersensitivity of NaP or PEG solution. (As to PEG solution only 4, 5 and 6 are true of contraindication.) B. Those who are under 20 years old or 75 years old or more, or those who are 65 years old or more taking medicine which affect renal blood flow or function (such as diuretic, angiotensin-converting enzyme inhibitor, angiotensin-receptor antagonist, NSAIDs ). C. Those who are severely constipated (those who habitually take purgative or those who have less than 3 bowel movements a week). D. Those who have had their digestive tract operated (except a history of appendicitis operation) E. Those women who are pregnant, breast-feeding, or suspected of being pregnant. F. In addition, those who are judged to be inappropriate by doctors.

发起方

TT Medical Center Tokyo, Gastroenterology Division